These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28721383)

  • 21. Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients.
    Beltrán M; Alonso MC; Ojeda MB; Izquierdo A; Ferrer J; Picó C; Anglada L; Catalán G; Batiste-Alentorn E; Tusquets I
    Ann Oncol; 1991 Jul; 2(7):495-9. PubMed ID: 1832944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.
    Lubian López DM; Fernandez YG; Rodríguez BR; López FM; Delgado RC
    Menopause; 2010; 17(3):487-93. PubMed ID: 20464783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients.
    Kavak ZN; Binöz S; Ceyhan N; Pekin S
    Acta Obstet Gynecol Scand; 2000 Jul; 79(7):604-7. PubMed ID: 10929963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.
    Barakat RR; Gilewski TA; Almadrones L; Saigo PE; Venkatraman E; Hudis C; Hoskins WJ
    J Clin Oncol; 2000 Oct; 18(20):3459-63. PubMed ID: 11032585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies.
    Cohen I; Tepper R; Rosen DJ; Shapira J; Cordoba M; Dror Y; Altaras M; Beyth Y
    Gynecol Oncol; 1994 Oct; 55(1):138-43. PubMed ID: 7959255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer.
    López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC
    Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients.
    Cohen I; Perel E; Flex D; Tepper R; Altaras MM; Cordoba M; Beyth Y
    J Clin Pathol; 1999 Apr; 52(4):278-82. PubMed ID: 10474520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation.
    Hulka CA; Hall DA
    AJR Am J Roentgenol; 1993 Apr; 160(4):809-12. PubMed ID: 8456669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tamoxifen effects on endometrium.
    Colacurci N; De Seta L; De Franciscis P; Mele D; Fortunato N; Cassese S
    Panminerva Med; 2000 Mar; 42(1):45-7. PubMed ID: 11019604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women.
    Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
    Gynecol Oncol; 2005 Jul; 98(1):63-7. PubMed ID: 15894357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen.
    Beşe T; Kösebay D; Demirkiran F; Arvas M; Beşe N; Mandel N
    Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):157-62. PubMed ID: 8841805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial.
    Gardner FJ; Konje JC; Abrams KR; Brown LJ; Khanna S; Al-Azzawi F; Bell SC; Taylor DJ
    Lancet; 2000 Nov; 356(9243):1711-7. PubMed ID: 11095258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen and endometrial pathologies: a prospective study.
    Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
    Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of tamoxifen on the endometrium.
    Uziely B; Lewin A; Brufman G; Dorembus D; Mor-Yosef S
    Breast Cancer Res Treat; 1993; 26(1):101-5. PubMed ID: 8400318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
    Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.